Development of an ALDH2-targeting rnai therapeutic for alcohol use disorders

Ended Cooperative Agreement Awarded Last action

Award ID
U44AA027404
Recipient
Awarding agency
Obligated
$8,000,000

Award facts

Assistance listing
93.273 Alcohol Research Programs
Completion date
Originally
Funding
  • $6,500,000.00 Federal
  • $1,500,000.00 Non-federal
Place of performance
Massachusetts, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment -$19,306 $0
Amendment -$1,000,000 $0
Amendment $1,019,306 $0
Amendment -$19,306 -$19,306
Amendment $1,019,306 $1,019,306
Amendment -$1,000,000 -$1,000,000
Amendment $0 $0
Amendment $0 $0
Amendment $1,500,000 $0
Amendment $1,500,000 $1,500,000
Amendment $1,500,000 $0
Amendment $1,000,000 $0
Original award $1,000,000 $0
Show all 17

Quick answers

Who received award U44AA027404?

U44AA027404 was awarded to Dicerna Pharmaceuticals, Inc. by National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health) on September 20, 2018.

How much is award U44AA027404 worth?

$8,000,000 has been obligated on U44AA027404: $6,500,000 in federal funding and $1,500,000 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award